Clinical Trial Update: Anti-inflammatory Effects of Simvastatin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating anti-inflammatory effects of simvastatin was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypercholesterolemia
• Inflammation

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: paresh Dandona | Conditions: Inflammation, Atherosclerosis | Phase 4 | Status: TERMINATED | Results posted: 2024-01-23